March 26, 2020 / 6:09 AM / 15 days ago

BRIEF-Biocartis Announces Co-Commercialisation Agreement For SeptiCyte RAPID Test

March 26 (Reuters) - BIOCARTIS GROUP NV:

* BIOCARTIS ANNOUNCES CO-COMMERCIALIZATION OF THE SEPTICYTE® RAPID TEST ON IDYLLA™ (CE-IVD) AND PROVIDES UPDATE ON COVID-19 IMPACT

* COVID-19: EXPECTS THAT CURRENT PROLONGED MEASURES TAKEN IN MANY COUNTRIES ACROSS GLOBE MAY POTENTIALLY IMPACT FY 2020 OUTLOOK OF COMPANY Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below